• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

列线图预测甲状腺乳头状癌中央区淋巴结转移。

Nomogram to predict central lymph node metastasis in papillary thyroid carcinoma.

机构信息

Department of Thyroid Surgery, Affiliated Hospital of Southwest Medical University, 25 Taiping Street, Luzhou, 646000, Sichuan Province, China.

Operating Room of Affiliated Hospital of Southwest Medical University, Luzhou, China.

出版信息

Clin Exp Metastasis. 2024 Oct;41(5):613-626. doi: 10.1007/s10585-024-10285-3. Epub 2024 Apr 3.

DOI:10.1007/s10585-024-10285-3
PMID:38568295
Abstract

Central lymph node metastasis (CLNM) of papillary thyroid carcinoma (PTC) is common. In our study, we built a nomogram to predict CLNM. We retrospectively analyzed 1,392 PTC patients. This group of patients was divided into a training cohort (including 1,009 patients) and a validation cohort (including 383 patients). Analyses of the correlation between inflammatory indicators, ultrasonic characteristics, pathological characteristics and CLNM were conducted. In the training cohort and validation cohort, the metastatic rates of CLNM were 60.16% and 64.23%, respectively. Univariate and multivariate logistic regression analyses demonstrated that Hashimoto's thyroiditis (HT), calcification, multifocality, capsule invasion, PLR (platelet-lymphocyte ratio) ≤ 130.34, large tumors and middle and lower positions were independent risk factors for CLNM. Then, we constructed a nomogram. The nomogram had good discrimination regardless of whether there was CLNM, with a C-index of 0.809. The calibration curve indicated that the nomogram had good visual and quantitative consistency (p = 0.213). Decision curve analysis showed that the nomogram improved the net clinical benefit with a threshold probability of 0-82% in the training cohort and 0-71% in the validation cohort. We constructed a nomogram to predict CLNM in PTC and assist surgeons in making personalized clinical decisions for PTC.

摘要

甲状腺乳头状癌(PTC)的中央区淋巴结转移(CLNM)较为常见。在本研究中,我们构建了一个列线图来预测 CLNM。我们回顾性分析了 1392 例 PTC 患者。将这组患者分为训练队列(包括 1009 例患者)和验证队列(包括 383 例患者)。分析了炎症指标、超声特征、病理特征与 CLNM 之间的相关性。在训练队列和验证队列中,CLNM 的转移率分别为 60.16%和 64.23%。单因素和多因素 logistic 回归分析表明,桥本甲状腺炎(HT)、钙化、多灶性、包膜侵犯、血小板淋巴细胞比值(PLR)≤130.34、肿瘤较大以及中下部位置是 CLNM 的独立危险因素。然后,我们构建了一个列线图。该列线图在有无 CLNM 时均具有良好的区分度,C 指数为 0.809。校准曲线表明,该列线图具有良好的视觉和定量一致性(p=0.213)。决策曲线分析显示,在训练队列和验证队列中,该列线图在阈值概率为 0-82%和 0-71%时提高了净临床获益。我们构建了一个预测 PTC 患者 CLNM 的列线图,以帮助外科医生为 PTC 患者做出个性化的临床决策。

相似文献

1
Nomogram to predict central lymph node metastasis in papillary thyroid carcinoma.列线图预测甲状腺乳头状癌中央区淋巴结转移。
Clin Exp Metastasis. 2024 Oct;41(5):613-626. doi: 10.1007/s10585-024-10285-3. Epub 2024 Apr 3.
2
Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: a practical nomogram based on retrospective study.预测合并桥本甲状腺炎的乳头状甲状腺癌中央区颈淋巴结转移:基于回顾性研究的实用列线图
PeerJ. 2024 Apr 19;12:e17108. doi: 10.7717/peerj.17108. eCollection 2024.
3
Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.术前预测 cN0T1/T2 期甲状腺乳头状癌中央区淋巴结转移:基于临床和超声特征的列线图
Eur J Surg Oncol. 2022 Jun;48(6):1272-1279. doi: 10.1016/j.ejso.2022.04.001. Epub 2022 Apr 6.
4
A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor.桥本甲状腺炎合并甲状腺乳头状癌中央区淋巴结转移的综合预测模型:BRAF 可能不是一个有价值的预测指标。
Front Endocrinol (Lausanne). 2024 Sep 19;15:1429382. doi: 10.3389/fendo.2024.1429382. eCollection 2024.
5
Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.基于术前血清甲状腺球蛋白和甲状腺乳头状癌临床特征的列线图模型预测颈部淋巴结转移。
Front Endocrinol (Lausanne). 2022 Jul 15;13:937049. doi: 10.3389/fendo.2022.937049. eCollection 2022.
6
An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study.基于深度学习、临床特征和超声特征的综合列线图预测甲状腺乳头状癌中央区淋巴结转移:一项多中心研究。
Front Endocrinol (Lausanne). 2023 Feb 21;14:964074. doi: 10.3389/fendo.2023.964074. eCollection 2023.
7
Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.桥本甲状腺炎与经典型甲状腺乳头状癌中央区淋巴结转移相关:来自大容量单中心经验的分析。
Front Endocrinol (Lausanne). 2022 May 20;13:868606. doi: 10.3389/fendo.2022.868606. eCollection 2022.
8
The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.预测伴有桥本甲状腺炎的 cN0 期甲状腺微小乳头状癌中央区淋巴结转移的模型。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1330896. doi: 10.3389/fendo.2024.1330896. eCollection 2024.
9
Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus.颈中部孤立性甲状腺乳头状癌中央区淋巴结转移风险预测列线图的建立与验证。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14853-14868. doi: 10.1007/s00432-023-05146-7. Epub 2023 Aug 20.
10
An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation.伴有 BRAF V600E 突变的甲状腺乳头状癌中央区淋巴结转移的在线模型。
Am J Clin Oncol. 2024 Aug 1;47(8):383-390. doi: 10.1097/COC.0000000000001109. Epub 2024 Apr 24.

引用本文的文献

1
AI-based multimodal prediction of lymph node metastasis and capsular invasion in cT1N0M0 papillary thyroid carcinoma.基于人工智能的cT1N0M0期甲状腺乳头状癌淋巴结转移和包膜侵犯的多模态预测
Front Endocrinol (Lausanne). 2025 May 27;16:1580885. doi: 10.3389/fendo.2025.1580885. eCollection 2025.
2
Clinical performance of a machine learning-based model for detecting lymph node metastasis in papillary thyroid carcinoma: A multicenter study.基于机器学习的乳头状甲状腺癌淋巴结转移检测模型的临床性能:一项多中心研究。
Int J Surg. 2025 Jun 1;111(6):4062-4067. doi: 10.1097/JS9.0000000000002400. Epub 2025 Apr 22.

本文引用的文献

1
Diagnosing postoperative lymph node metastasis in thyroid cancer with multimodal radiomics and clinical features.利用多模态影像组学和临床特征诊断甲状腺癌术后淋巴结转移
Digit Health. 2024 Feb 20;10:20552076241233244. doi: 10.1177/20552076241233244. eCollection 2024 Jan-Dec.
2
Related factor analysis for predicting large-volume central cervical lymph node metastasis in papillary thyroid carcinoma.预测甲状腺乳头状癌中央颈侧区大容量淋巴结转移的相关因素分析。
Front Endocrinol (Lausanne). 2022 Aug 15;13:935559. doi: 10.3389/fendo.2022.935559. eCollection 2022.
3
Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.
桥本甲状腺炎与经典型甲状腺乳头状癌中央区淋巴结转移相关:来自大容量单中心经验的分析。
Front Endocrinol (Lausanne). 2022 May 20;13:868606. doi: 10.3389/fendo.2022.868606. eCollection 2022.
4
Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.术前预测桥本甲状腺炎合并甲状腺乳头状癌患者中央区淋巴结转移
Front Endocrinol (Lausanne). 2021 Jul 22;12:713475. doi: 10.3389/fendo.2021.713475. eCollection 2021.
5
Predictors of Central Compartment Involvement in Patients with Positive Lateral Cervical Lymph Nodes According to Clinical and/or Ultrasound Evaluation.根据临床和/或超声评估,预测外侧颈部淋巴结阳性患者中央区受累的因素。
J Clin Med. 2021 Jul 30;10(15):3407. doi: 10.3390/jcm10153407.
6
Skip Metastases in Papillary Thyroid Carcinoma - Prevalence, Predictive and Clinicopathological Factors.甲状腺乳头状癌中的跳跃式转移——患病率、预测因素和临床病理因素。
Acta Clin Croat. 2020 Jun;59(Suppl 1):122-128. doi: 10.20471/acc.2020.59.s1.16.
7
Prophylactic Central Neck Dissection in Papillary Thyroid Carcinoma: All Risks, No Reward.预防性中央区颈部清扫术在甲状腺乳头状癌中的应用:全是风险,没有获益。
J Surg Res. 2021 Aug;264:230-235. doi: 10.1016/j.jss.2021.02.035. Epub 2021 Apr 8.
8
Development and Validation of a Nomogram for Preoperative Prediction of Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma and Type 2 Diabetes Mellitus.甲状腺乳头状癌合并2型糖尿病患者中央区淋巴结转移术前预测列线图的开发与验证
Cancer Manag Res. 2021 Mar 17;13:2499-2513. doi: 10.2147/CMAR.S300264. eCollection 2021.
9
Predictive Value of Delphian Lymph Node Metastasis in the Thyroid Cancer.Delphian 淋巴结转移对甲状腺癌的预测价值。
Laryngoscope. 2021 Sep;131(9):1990-1996. doi: 10.1002/lary.29426. Epub 2021 Jan 25.
10
Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.成人低危甲状腺微小乳头状癌主动监测的适应证和策略:日本内分泌外科学会甲状腺微小乳头状癌管理工作组的共识声明。
Thyroid. 2021 Feb;31(2):183-192. doi: 10.1089/thy.2020.0330. Epub 2020 Nov 2.